| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FASEBJ.14.5.715 |
| P8608 | Fatcat ID | release_oa4gqpw7g5d4pdx2hx52z567da |
| P698 | PubMed publication ID | 10744628 |
| P2093 | author name string | Lin Z | |
| Uhl GR | |||
| Itokawa M | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 715-728 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. | |
| P478 | volume | 14 |
| Q30623808 | A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters |
| Q30397145 | Classic Studies on the Interaction of Cocaine and the Dopamine Transporter |
| Q32062587 | Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. |
| Q37266288 | Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporter |
| Q44247694 | Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations |
| Q36215945 | Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux |
| Q30336154 | Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism |
| Q36944251 | HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes |
| Q37672037 | HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. |
| Q44483562 | Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities |
| Q35581528 | Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter |
| Q36429668 | Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain |
| Q64860855 | Model systems for analysis of dopamine transporter function and regulation |
| Q44667602 | Molecular model of the neural dopamine transporter |
| Q44568811 | Mutation of proline residues in the NH(2)-terminal region of the multidrug resistance protein, MRP1 (ABCC1): effects on protein expression, membrane localization, and transport function |
| Q35581525 | Probing dopamine transporter structure and function by Zn2+-site engineering |
| Q40606578 | Proline residues in transmembrane segment IV are critical for activity, expression and targeting of the Na+/H+ exchanger isoform 1. |
| Q28365617 | Proline residues in two tightly coupled helices of the sulphate transporter, SHST1, are important for sulphate transport |
| Q28476265 | Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters |
| Q38627498 | Residues in the eighth transmembrane domain of the proton-coupled folate transporter (SLC46A1) play an important role in defining the aqueous translocation pathway and in folate substrate binding |
| Q36899287 | Role of conserved prolines in the structure and function of the Na+/dicarboxylate cotransporter 1, NaDC1. |
| Q40683750 | The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter |
| Q33813126 | The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter |
| Q35581491 | The top 20 dopamine transporter mutants: structure–function relationships and cocaine actions |
| Q43823452 | Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology |
Search more.